IRIS
BRAIDO, FULVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.365
Totale 16.365
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 16.365
Totale 16.365
Salva come PNG Salva come JPEG
Città #
Genova 13.168
Rapallo 1.920
Genoa 1.212
Bordighera 65
Totale 16.365
Salva come PNG Salva come JPEG
Nome #
null 200
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 147
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 142
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 140
Genuair® Usability Test: Results of a National Public Survey of the Elderly 135
Antiallergic drugs and quality of life. 130
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 130
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 128
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 127
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 127
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 124
The relationship between allergen immunotherapy and omalizumab for treating asthma 123
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 123
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 122
RhinAsthma patient perspective: A Rasch validation study 121
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 119
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 119
Allergic diseases and their impact on quality of life. 118
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 118
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 117
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 116
New therapies for allergic rhinitis 116
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 116
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 116
An update on allergen immunotherapy and asthma 115
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 115
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 115
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 114
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 114
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 113
Long-acting bronchodilators improve health related quality of life in patients with COPD. 113
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 113
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 113
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 112
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 111
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 111
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 111
Continuing Medical Education:an international reality 111
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 111
Why do doctors and patients not follow guidelines? 110
Worldwide differences on the concept of control of asthma. 110
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 110
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 110
Quality-of-life issues in survivors to anaphylactic reactions to drugs 110
Patient-reported outcomes in asthma clinical trials 110
Asthma treatment: 'magic bullets which seek their own targets'. 110
Biosimilars in allergic diseases 110
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 108
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 108
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 108
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 106
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 104
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 104
Sleep disturbances in allergic diseases. 103
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 103
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 103
Umeclidinium for the treatment of uncontrolled asthma 103
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 103
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 102
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 102
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 102
Disease awareness in patients with COPD: measurement and extent 102
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 101
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 101
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 101
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 101
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 101
The link between allergic rhinitis and asthma: the united airways disease. 100
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab. 100
Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. 100
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. 100
The anti-inflammatory properties of tiotropium 99
Coping with asthma: is the physician able to identify patient's behaviour? 98
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 97
Sleep apnea risk in subjects with asthma with or without comorbid rhinitis 97
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 97
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 97
Phenotypes/endotypes-driven treatment in asthma 97
LABA/LAMA Fixed Dose Combination in Chronic Obstructive Pulmonary Disease: The Impact on Health-Related Quality of Life 97
The role of Pneumococcal vaccine 97
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 97
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. 96
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. 96
Pidotimod: The state of art 96
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 96
Disability in COPD and its relationship to clinical and patient-reported outcomes 95
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 95
Adherence to asthma treatments: 'We know, we intend, we advocate' 94
Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria 93
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 93
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 93
Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations 93
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? 91
null 90
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 90
Pharmacotherapy of allergic rhinitis: current options and future perspectives 89
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 89
Adherence to treatment: assessment of an unmet need in asthma. 88
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 88
Quality standards for the management of bronchiectasis in Italy: A national audit 88
Totale 10.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.051
article - articoli 48.607
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 444
Totale 98.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019993 0 0 0 0 0 0 0 0 0 195 415 383
2019/20205.549 232 129 213 379 491 603 993 472 620 795 507 115
2020/20211.886 117 119 224 240 115 127 127 176 126 202 150 163
2021/20222.448 129 164 117 243 53 251 119 572 182 216 106 296
2022/20232.336 250 121 23 241 329 414 72 186 407 56 190 47
2023/2024895 61 162 24 118 99 173 92 81 59 26 0 0
Totale 16.991